Abstract

Background and purposeDaily cone-beam computed tomography (CBCT) in image-guided radiotherapy administers radiation exposure and subjects patients to secondary cancer risk. Reducing imaging dose remains challenging as image quality deteriorates. We investigated three imaging dose levels by reducing projections and correcting images using two deep learning algorithms, aiming at identifying the lowest achievable imaging dose. Materials and methodsCBCTs were reconstructed with 100%, 25%, 15% and 10% projections. Models were trained (30), validated (3) and tested (8) with prostate cancer patient datasets. We optimized and compared the performance of 1) a cycle generative adversarial network (cycleGAN) with residual connection and 2) a contrastive unpaired translation network (CUT) to generate synthetic computed tomography (sCT) from reduced imaging dose CBCTs. Volumetric modulated arc therapy plans were optimized on a reference intensity-corrected full dose CBCTcor and recalculated on sCTs. Hounsfield unit (HU) and positioning accuracy were evaluated. Bladder and rectum were manually delineated to determine anatomical fidelity. ResultsAll sCTs achieved average mean absolute mean absolute error/structural similarity index measure/peak signal-to-noise ratio of ⩽59HU/⩾0.94/⩾33 dB. All dose-volume histogram parameter differences were within 2 Gy or 2%. Positioning differences were ⩽0.30 mm or 0.30°. cycleGAN with Dice similarity coefficients (DSC) for bladder/rectum of ⩾0.85/⩾0.81 performed better than CUT (⩾0.83/⩾0.76). A significantly lower DSC accuracy was observed for 15% and 10% sCTs. cycleGAN performed better than CUT for contouring, however both yielded comparable outcomes in other evaluations. ConclusionsCTs based on different CBCT doses using cycleGAN and CUT were investigated. Based on segmentation accuracy, 25% is the minimum imaging dose.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.